Liquid Biopsy
News and reporting on cell-free DNA testing.
Personalis, Tempus Partner to Commercialize Blood-Based Minimal Residual Disease Test
Tempus will market Personalis' NeXT Personal Dx liquid biopsy while Personalis completes its clinical validation in more indications.
Foundation Medicine, Pierre Fabre Laboratories to Collaborate on CDx for Lung Cancer
The companies will seek approval for Foundation Medicine's assays identifying patients for treatment with Pierre Fabre's BRAF/MEK inhibitor combination regimen.
Guardant Health, Flatiron Health Forge Genomic Profiling Test Deal
The firms will integrate Guardant's genomic profiling tests for early- and advanced-stage cancers into Flatiron's cloud-based electronic medical record tool.
Liquid Biopsy Startup Aqtual Raises $16M in Series A Financing
The startup will analyze cell-free DNA to develop blood-based assays to guide treatment in chronic diseases and oncology, starting with rheumatoid arthritis.
City of Hope, TGen Win $4.5M Grant to Advance Pancreatic Cancer Liquid Biopsy Screening
A City of Hope-led consortium aims to validate a noninvasive screening test for pancreatic ductal adenocarcinoma in a large-scale, diverse cohort.